- Featured Product
- KD/KO Validated
P21 Monoclonal Antibody for WB, ELISA
Cat no : 60214-1-Ig
CAP20, CDK interacting protein 1, CDKN1, CDKN1A, CIP1, MDA 6, MDA6, P21, p21CIP1, PIC1, SDI1, WAF1
|Positive WB detected in||MCF-7 cells, HEK-293 cells, HeLa cells, HUVEC cells|
|Western Blot (WB)||WB : 1:500-1:2000|
|Sample-dependent, check data in validation data gallery|
The 60214-1-Ig immunogen is Fusion Protein P21 protein expressed in E. coli.
|Host / Isotype||Mouse / IgG2b|
|Immunogen||P21 fusion protein Ag0308|
|Full Name||cyclin-dependent kinase inhibitor 1A (p21, Cip1)|
|Calculated molecular weight||21 kDa|
|Observed molecular weight||21 kDa|
|GenBank accession number||BC000312|
|Gene ID (NCBI)||1026|
|Purification Method||Protein A purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
CDKN1A (p21, CIP1, WAF1), a cyclin-dependent kinase inhibitor, is necessary for proper control of the cell cycle and premature senescence. P21 is a cyclin-dependent kinase (CDK) inhibitor that suppresses proliferation by inhibiting CDK2 and CDK1 activity at the G1/S and G2/M transitions. P21 is a major mediator of p53 to induce cell cycle arrest in G1. p21 can interact with proliferating cell nuclear antigen (PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. P21 was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Overexpression of p21 decreases the expression levels of cell cycle progression genes and upregulates senescence-inducing genes.
J Exp Clin Cancer Res
GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
J Cell Physiol
HOXC13-AS promotes breast cancer cell growth through regulating miR-497-5p/PTEN axis.
Bosn J Basic Med Sci
CircRNA_014511 affects the radiosensitivity of bone marrow mesenchymal stem cells by binding to miR-29b-2-5p.
Oncol Res Treat
GAS5 Inhibits Gastric Cancer Cell Proliferation Partly by Modulating CDK6.
MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3.
Mol Med Rep
Ginsenoside Rg1 ameliorates testicular senescence changes in D‑gal‑induced aging mice via anti‑inflammatory and antioxidative mechanisms.